Advances in Pharmacological and Pharmaceutical Sciences / 2022 / Article / Tab 5 / Research Article
Willingness, Attitude, and Associated Factors towards Adverse Drug Reaction Reporting among Healthcare Providers in Mizan Tepi University Teaching Hospital, Southwest Ethiopia Table 5 Attitude of healthcare providers towards ADR reporting in Mizan Tepi University Teaching Hospital from August to September 2021.
Variables N (%)Strongly agree Agree Neutral Disagree Strongly disagree ADR reporting is duty of health professionals 115 (60.5) 65 (34.2) 3 (1.6) 5 (2.6) 2 (1.1) ADRs need to be sure before reporting 79 (41.6) 96 (50.5) 4 (2.1) 10 (5.3) 1 (0.5) ADR report improves patient’s safety 81 (42.6) 86 (45.3) 11 (5.8) 11 (5.8) 1 (0.5) All suspected ADRs should be reported 39 (20.5) 56 (29.5) 47 (24.7) 46 (24.2) 2 (1.1) ADR reporting trends identify relatively safe drugs 45 (23.7) 92 (48.4) 33 (17.4) 17 (8.9) 3 (1.6) ADR reporting creates workload 21 (11.1) 37 (19.5) 49 (25.8) 72 (37.9) 11 (5.8) ADR reporting is not important for the healthcare system 12 (6.3) 23 (12.1) 18 (9.5) 82 (43.2) 55 (28.9) Reporting of ADR affects patient’s confidentiality issues 15 (7.9) 35 (18.4) 31 (16.3) 85 (44.7) 24 (12.6) A single ADR report brings no difference 10 (5.3) 22 (11.6) 37 (19.5) 93 (48.9) 28 (14.7) Fear of legal liability affects ADR reporting 32 (16.8) 40 (21.1) 37 (19.5) 66 (34.7) 15 (7.9)